238 related articles for article (PubMed ID: 11258620)
1. Development of ribozymes that target stathmin, a major regulator of the mitotic spindle.
Mistry SJ; Benham CJ; Atweh GF
Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):41-9. PubMed ID: 11258620
[TBL] [Abstract][Full Text] [Related]
2. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Phylactou LA; Tsipouras P; Kilpatrick MW
Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
[TBL] [Abstract][Full Text] [Related]
3. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
Kisich KO; Freedland SJ; Erickson KL
Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
[TBL] [Abstract][Full Text] [Related]
4. Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.
Iancu C; Mistry SJ; Arkin S; Atweh GF
Cancer Res; 2000 Jul; 60(13):3537-41. PubMed ID: 10910066
[TBL] [Abstract][Full Text] [Related]
5. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
Tabler M; Homann M; Tzortzakaki S; Sczakiel G
Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
[TBL] [Abstract][Full Text] [Related]
6. Length variation of helix III in a hammerhead ribozyme and its influence on cleavage activity.
Hammann C; Martinez E; Moosbauer J; Hormes R; Tabler M
Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):25-31. PubMed ID: 10192286
[TBL] [Abstract][Full Text] [Related]
7. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy.
Mistry SJ; Atweh GF
Mt Sinai J Med; 2002 Oct; 69(5):299-304. PubMed ID: 12415323
[TBL] [Abstract][Full Text] [Related]
8. A helix 1-extended hairpin ribozyme exhibits altered cleavage behavior in vitro.
Moosbauer J; Tabler M
Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):79-87. PubMed ID: 9149843
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
Denman RB
Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
[TBL] [Abstract][Full Text] [Related]
10. Effects of stathmin inhibition on the mitotic spindle.
Iancu C; Mistry SJ; Arkin S; Wallenstein S; Atweh GF
J Cell Sci; 2001 Mar; 114(Pt 5):909-16. PubMed ID: 11181174
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
[TBL] [Abstract][Full Text] [Related]
13. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
14. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
[TBL] [Abstract][Full Text] [Related]
15. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
16. Biological and functional aspects of catalytic RNAs.
Castanotto D; Rossi JJ; Deshler JO
Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242
[TBL] [Abstract][Full Text] [Related]
17. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
Sioud M
Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
[TBL] [Abstract][Full Text] [Related]
18. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
19. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.
Chen Z; Kamath P; Zhang S; St John L; Adler-Storthz K; Shillitoe EJ
Cancer Gene Ther; 1996; 3(1):18-23. PubMed ID: 8785706
[TBL] [Abstract][Full Text] [Related]
20. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
